KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Astrana Health (ASTH) Invested Capital (2016 - 2025)

Astrana Health (ASTH) has disclosed Invested Capital for 15 consecutive years, with $827.2 million as the latest value for Q4 2025.

  • Quarterly Invested Capital rose 14.55% to $827.2 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $827.2 million through Dec 2025, up 14.55% year-over-year, with the annual reading at $827.2 million for FY2025, 14.55% up from the prior year.
  • Invested Capital hit $827.2 million in Q4 2025 for Astrana Health, roughly flat from $823.4 million in the prior quarter.
  • In the past five years, Invested Capital ranged from a high of $827.2 million in Q4 2025 to a low of $347.4 million in Q1 2021.
  • Historically, Invested Capital has averaged $599.8 million across 5 years, with a median of $585.5 million in 2023.
  • Biggest YoY gain for Invested Capital was 91.9% in 2021; the steepest drop was 18.84% in 2021.
  • Year by year, Invested Capital stood at $455.6 million in 2021, then rose by 20.78% to $550.2 million in 2022, then rose by 12.38% to $618.3 million in 2023, then grew by 16.78% to $722.1 million in 2024, then grew by 14.55% to $827.2 million in 2025.
  • Business Quant data shows Invested Capital for ASTH at $827.2 million in Q4 2025, $823.4 million in Q3 2025, and $784.0 million in Q2 2025.